Cutaneous tumors during xeroderma pigmentosum in Morocco: Study of 120 patients;Tumeurs cutanées au cours du xeroderma pigmentosum au Maroc: Etude de 120 malades

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 1 I, 2004, Pages 29-33

  Moussaid, L ^a,e   Benchikhi, H ^a   Boukind, E H ^b   Sqalli, S ^c   Mouaki, N ^d   Kadiri, F ^d   Lakhdar, H ^a  

^a Serv de Dermatologie Venereologie   (France)

^b Service de Chirurgie Plastique

^c Service d'Anatomopathologie

^d IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^e NONE   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BASAL CELL CARCINOMA; CANCER RECURRENCE; CANCER SIZE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCOAGULATION; EYE TUMOR; FEMALE; FOLLOW UP; GENODERMATOSIS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOROCCO; SKIN CARCINOMA; SKIN GRAFT; SKIN PROTECTION; SQUAMOUS CELL CARCINOMA; XERODERMA PIGMENTOSUM;

EID: 1442276310     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(04)93538-7     Document Type: Article

References (17)

1. Sarasin A. Les gènes humains de la réparation de l'ADN. Médecine Sciences 1994;10:43-5.
2. Stary A, Sarasin A. Le xeroderma pigmentosum. Presse Med 1997;26:1992-7.
3. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum: cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 1987;123;241-50.
4. Fazaa B, Kamoun MR. Xeroderma pigmentosum. Ann Dermatol Venereol 2003;130:69-73.
5. Spirito F, Meneguzzi G, Danos O, Mezzina M. Cutaneous gene transfer and therapy: the present and the future. J Gene Med 2001;3:21-3.
6. Zghal M, Fazaa B, Zghal A, Mokhtar I. Les particularités cliniques et génétiques du xeroderma pigmentosum du groupe A en Tunisie. Ann Dermatol Venereol 1999;126 (Suppl 2):2S79-2S80.
7. Khatri M, Bemghazil M, Shafi M. Xeroderma pigmentosum in Lybya. Int J Dermatol 1999;38:520-4.
8. e Congrès Maghrébin de Dermatologie-Véné réologie, Tunis-Carthage, 2000;P33:20-3.
9. Fazaa B, Zghal M, Zermani A, Zarrouk H. Les tumeurs cutanées malignes au cours du xeroderma pigmentosum. Rapport de congrès: Premier congrès de la Société Maghrébine de Dermatologie et de Vénéréologie, Rabat, 7-9 avril 1994.
10. Bouadjar B, Ait Belkacem F, Daya-Grosjean L. Xeroderma pigmentosum. Etude de 40 malades algériens. Ann Dermatol Venereol 1996;123:303-6.
11. Nejjam F, Jarmouni R, Habibeddine S, Lakhdar H. Xeroderma pigmentosum (176 cas). Rev Maroc Med Santé 1992;14:33-7.
12. Gharbi MR. - Xeroderma pigmentosum. Ther Umsch 1982;39:193-201.
13. Takebe H, Nishigori C, Satoh Y. Genetics and skin cancer of xeroderma pigmentosum in Japan. Jpn J Cancer Res 1987;78:1135-43.
14. Kraemer KH, Slor H. Xeroderma pigmentosum. Clin Dermatol 1984;2:33-69.
15. English JS, Swerdlow AJ. The risk of malignant melanoma, internal malignancy and mortality in xeroderma pigmentosum patients. Br J Dermatol 1987;117:457-61.
16. Lynch HT, Fusaro RM, Johnson JA. Xeroderma pigmentosum - complementation group C and malignant melanoma. Arch Dermatol 1984;120:175-9.
17. Yarosh D, Klein J, O'Connor A, Hawk J, Rafal E, Wolf P. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Lancet 2001;357:926-9.